Recent discussions on X about DocuSign (DOCU) have centered around the company's latest Q2 earnings report, which exceeded expectations with a reported revenue of $800.6 million, marking an 8.8% year-over-year increase, and an EPS of $0.92. Many users have highlighted the company's upward revision of its full-year 2026 sales guidance and a strong Q3 outlook, sparking renewed interest in the stock as it gapped up nearly 9% following the announcement. The buzz also includes mentions of accelerating adoption of AI tools, which some believe could drive future growth.
Additionally, there’s a notable focus on the stock’s technical performance, with posts pointing to a significant intraday surge and potential resistance levels that could influence its trajectory. Some discussions express optimism about the stock’s momentum, especially given institutional support and its position well above the 52-week low. The conversation reflects a dynamic mix of fundamental and technical analysis among participants on the platform.
Note: This discussion summary was generated from an AI condensation of post data.
DocuSign Congressional Stock Trading
Members of Congress have traded $DOCU stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $DOCU stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DocuSign Insider Trading Activity
DocuSign insiders have traded $DOCU stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales.
Here’s a breakdown of recent trading of $DOCU stock by insiders over the last 6 months:
- ALLAN C. THYGESEN (President and CEO) has made 0 purchases and 6 sales selling 80,000 shares for an estimated $6,376,330.
- BLAKE JEFFREY GRAYSON (Chief Financial Officer) has made 0 purchases and 9 sales selling 50,468 shares for an estimated $3,948,834.
- ROBERT CHATWANI (President General Mgr, Growth) has made 0 purchases and 9 sales selling 38,581 shares for an estimated $3,017,422.
- JAMES P SHAUGHNESSY (Chief Legal Officer) has made 0 purchases and 4 sales selling 15,000 shares for an estimated $1,189,662.
- TERESA BRIGGS has made 0 purchases and 2 sales selling 1,068 shares for an estimated $86,390.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DocuSign Hedge Fund Activity
We have seen 369 institutional investors add shares of DocuSign stock to their portfolio, and 488 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 2,057,329 shares (-33.4%) from their portfolio in Q2 2025, for an estimated $160,245,355
- ALYESKA INVESTMENT GROUP, L.P. added 1,681,014 shares (+220.0%) to their portfolio in Q2 2025, for an estimated $130,934,180
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,384,959 shares (-97.7%) from their portfolio in Q2 2025, for an estimated $107,874,456
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,351,434 shares (+66.6%) to their portfolio in Q2 2025, for an estimated $105,263,194
- COATUE MANAGEMENT LLC removed 1,343,053 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $109,324,514
- MORGAN STANLEY added 1,246,059 shares (+47.2%) to their portfolio in Q2 2025, for an estimated $97,055,535
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,065,980 shares (+33.7%) to their portfolio in Q2 2025, for an estimated $83,029,182
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DocuSign Analyst Ratings
Wall Street analysts have issued reports on $DOCU in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 09/05/2025
- Citigroup issued a "Buy" rating on 06/09/2025
- Jefferies issued a "Buy" rating on 03/31/2025
- William Blair issued a "Outperform" rating on 03/17/2025
- Citizens Capital Markets issued a "Market Outperform" rating on 03/14/2025
To track analyst ratings and price targets for DocuSign, check out Quiver Quantitative's $DOCU forecast page.
DocuSign Price Targets
Multiple analysts have issued price targets for $DOCU recently. We have seen 14 analysts offer price targets for $DOCU in the last 6 months, with a median target of $91.0.
Here are some recent targets:
- Michael Turrin from Wells Fargo set a target price of $85.0 on 09/05/2025
- William Power from Baird set a target price of $90.0 on 09/05/2025
- Rishi Jaluria from RBC Capital set a target price of $95.0 on 09/05/2025
- Rob Owens from Piper Sandler set a target price of $90.0 on 09/05/2025
- Kirk Materne from Evercore ISI Group set a target price of $92.0 on 09/05/2025
- Karl Keirstead from UBS set a target price of $85.0 on 09/05/2025
- Brad Sills from B of A Securities set a target price of $102.0 on 09/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
